In the investigation of adults with liver disease, hepatic scintiscanning after intravenous administration of colloidal technetium sulphide (99mTc) is considered valuable because of its simple noninvasive nature and its well documented validity. It has been shown to be particularly important in the management of primary and secondary malignant disease of the liver and to a lesser extent in parenchymal focal and infiltrative disorders, and also in indicating possible extrahepatic biliary obstruction by diminished isotope uptake in the region of the portahepatis (Drum and Christacopoulos, 1972) .
In children hepatic scintiscanning has been used in the management of hepatic tumour (Piepsz et al., 1974) , in chronic granulomatous disease (Samuels, 1971) , and also for showing hepatic enlargement and possible abnormality in cystic fibrosis (Feigelson et al., 1972; Goodchild et al., 1975) . We are aware of no report of its systematic evaluation in infants and children with a variety of liver disorders, and therefore record our findings and assessment of the value of scanning in the management of 26 infants with obstructive liver disease and 37 children with clearly defined hepatic disorders. uptake, in some cases exceeding that of the liver. The appearance in cystic fibrosis was similar to that in cirrhosis except in one instance the liver was enlarged and the peak count rate normal. The scans from the 2 patients with congenital hepatic fibrosis both were large with a finely mottled appearance and a normal peak count rate. In both there was marked splenic enlargement and increased uptake. The scans from the 2 children with glycogen storage disease had a normal or reduced peak count rate with a patchy hepatic uptake and minimal splenic enlargement. 6 of 9 children with extrahepatic portal hypertension had small livers with even isotope uptake and a normal peak count rate. There was marked splenomegaly and a relatively low splenic uptake of the isotope. In all 5 children injected. Since the scan in no way influenced clinical management in this group of patients these technical difficulties reinforce our conclusion that liver scanning has no place at present in the management of infants with obstructive jaundice.
In older children as in adults, the main value of the scan was in excluding or showing space-occupying lesions of greater than 2 cm in diameter in children presenting with hepatomegaly of uncertain cause. This observation may be crucial in assessing the necessity for further investigations such as arteriography, or liver biopsy directed at the spaceoccupying lesion. An important new observation in this series of patients with hepatic tumour is that the cold area on the 99mTc scan which takes up selenomethionine 75 cannot necessarily be interpreted as a primary liver cell cancer since the haemangioendothelioma behaves similarly. Metastatic melanoma of the liver also takes up selenomethionine (Eddleston et al., 1971) . Ultrasonic echography, serum alphafetoprotein determination, hepatic arteriography, and tissue diagnosis must thus complement liver scanning in the management of patients with spaceoccupying lesions.
In chronic liver disease there is a tendency for patients in each pathological group to show a particular pattern of uptake by the liver and spleen, such as the reduced liver size, peak count rate, and enlarged spleen in cirrhosis, but there is considerable overlap among the various pathological groups. In these children the main value of the scan is in confirming the presence of liver disease when the biochemical and clinical findings are equivocal, pointing to the necessity for more definitive investigations which cause some discomfort and carry slight risks such as liver biopsy. It is also of value children with liver disease.
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